Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Government's site

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Aug 23, 2023 5:41pm

64 Views

Post# 35602756

RE:RE:RE:Government's site

Marathon is the problem. They are not the company's friend. Thera should find someone to take them out.

Trogarzon wrote: Maybe they know that announcing this now will trigger even more sceptism from their spending perspective and would prefer to fix the ongoing concern before hand. Renegociating the terms could do that in my book.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec